Fox Run Management, L.L.C. Emergent Bio Solutions Inc. Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.86 - $6.98 $20,532 - $77,052	11,039 New	11,039 $75,000
Q4 2021 Feb 09, 2022	SELL	$33.11 - $55.01 $247,000 - $410,374	-7,460 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $373,522 - $492,733	7,460 New	7,460 $374,000
Q4 2020 Feb 08, 2021	SELL	$79.17 - $111.47 $210,354 - $296,175	-2,657 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$81.91 - $134.94 $217,634 - $358,535	2,657 New	2,657 $275,000
Q2 2018 Jul 17, 2018	SELL	$48.33 - $55.64 $617,754 - $711,190	-12,782 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$44.44 - $54.39 $227,888 - $278,911	5,128 Added 67.0%	12,782 $673,000
Q4 2017 Jan 18, 2018	BUY	$37.77 - $47.75 $289,091 - $365,478	7,654	7,654 $356,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $427M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.